期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

拉西地平抗动脉粥样硬化作用的多效性 被引量：7

Pleiotropic Effects of Lacidipine on Atherosclerosis
暂未订购
导出
摘要 拉西地平是脂溶性第三代二氢吡啶类钙通道阻滞剂,具有强的抗氧化活性,不论是动物实验还是临床研究均证实,拉西地平具有抗动脉粥样硬化作用,且表现出多效性。 Lacidipine is a lipophilic third-generation dihydropyridine with antioxidant properties. A considerable body of experimental and clinical evidence has accumulated to support the suggestion that lacidipine have pleiotropic antiatherosclerotic effects that are independent of their hypotensive effects.
作者 徐国焱 吴可贵
机构地区 福建医科大学附属第一医院
出处 《心血管病学进展》 CAS 2008年第1期151-153,共3页 Advances in Cardiovascular Diseases
关键词 拉西地平 抗动脉粥样硬化作用 lacidipine antiatheroselerosis
分类号 R543.5 [医药卫生—心血管疾病]
  • 相关文献

参考文献20

  • 1Cominacini L, Fratta Pasini A, Garbin U, et al. Antioxidant activity of different dihydropyridines[ J]. Biochem Biophys Res Commun,2003,302(4) :6794584.
  • 2Sobal G, Menzel E J, Sinzinger H, et al. Calcium antagonists as inhibitors of in vitro low-density lipoprotein oxidation and glycation [ J ]. Biochem Pharmacol, 2001,61 (3) :373-379.
  • 3Berkels R, Breitenbach T, Barrels H, et al, Different antioxidative potencies of dihydropyridine calcium channel modulators in various models [ J ]. Vasc Pharmacol,2005,42 (4) : 145-152.
  • 4Rosenblat M,Coleman R, Aviram M,et al. Increased macrophage glutathione content reduces cell-mediated oxidation of LDL and atherosclerosis in apolipoprotein E-deficient mice [ J ]. Atherosclerosis,2002,163 : 17 -28.
  • 5Cristofori P, Crivellente F, Campagnola M, et al. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice treated with lacidipine is associated with a decreased susceptibility of low-density lipoprotein to oxidation [ J ]. Int J Exp Path,2004,85(2) :105-114.
  • 6Escames G, Khaldy H, Leon J, et al. Changes in iNOS activity, oxidative stress and melatonin levels in hypertensive patients treated with lacidipine [ J ]. J Hypertens,2004,22 ( 3 ) :6294535.
  • 7Kyselovic J,Martinka P,Batova Z,et al. Calcium channel blocker inhibits Western-type diet-evoked atherosclerosis development in apoE-deficient mice [ J ]. J Pharmacol Exp Ther,2005,315 ( 1 ) : 320-328.
  • 8Cristofori P, Lanzoni A, Gaviraghi G, et al. Anti-atherosclerotic activity of the calcium antagonist lacidipine in cholesterol-fed hamsters [ J ]. Biomed Pharmacother,2000,54(2) :93-99.
  • 9Cristofori PG,Crivellente FA,Faustinelli l,et al. Involvement of the nitric oxide system in the anti-atherosclerotic potential of lacidipine in the apoE-deficient mouse : a morphological, functional, and electrochemical study [ J ]. Toxicol Pathol,2004,32 (4) ;493-499.
  • 10Bae JH, Bassenge E, Lim DM,et al. Effects of lacidipine on vascular responses in patients with coronary artery disease [ J ]. Int J Cardiol,2005,101 (3) ;377- 383.

二级参考文献27

  • 1胡榕,吴可贵.核因子κB在心血管疾病中的作用的研究现状[J].中国动脉硬化杂志,2004,12(5):604-606. 被引量：17
  • 2[1]Yamada Y,Doi T,Hamakubo T,et al.Scavenger receptor family proteins:roles for atherosclerosis,host defence and disorders of the central nervous system[J].Cell Mol Life Sci,1998,54:628-640.
  • 3[2]Febbraio M,Hajjar DP,Silverstein RL.CD36:a class B scavenger receptor involved in angiogenesis,atherrosclerosis,inflammation,and lipid metabolism[J].J Clin Invest,2001,108:785-791.
  • 4[4]HuhHY,PearceSF,YesnerLM,et al.Regulated expression of CD36 during monocyte to macrophage differentiation:Potential role of CD36 in foam cell formation[J].Blood,1996,87:2020-2028.
  • 5[5]Nozaki S,Kashiwagi H,Yamashita S,et al.Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36 deficient subjects[J].J Clin Invest,1995,96:1859-1865.
  • 6[6]Febbraio M,Abumrad NA,Hajjar DP,et al.A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism[J].J Biol Chem,1999,274:19055-19062.
  • 7[7]Vidya V,Kunjathoor,Maria Febbraio,et al.Scavenger receptors class A-Ⅰ/Ⅱ and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages[J].J Biol Chem Vol December[J].2002,277,51:49982-49988.
  • 8[8]Moore KJ.Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice[J].J Clin Invest,2005,115:2192-2201.
  • 9[9]Nicholson A,Pearce SFA,Silverstein R.Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines.Evidence implicating the lipid moiety of the lipoprotein as the binding site[J].Arterioscler Thromb,1995,15:269-275.
  • 10[10]Boullier A,Gillotte KL,Horkko S,et al.The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein[J].J Biol Chem,2000,275,9163-9169.

共引文献8

同被引文献39

引证文献7

二级引证文献13

心血管病学进展
2008年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部